[Candida mycoses of mucous membranes].
D000666:Amphotericin B / Q000627:therapeutic use; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000188:drug therapy*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000209:etiology; D003270:Contraceptive Agents / Q000009:adverse effects; D005260:Female; D006099:Granuloma; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D010866:Natamycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D011247:Pregnancy
D003270:Contraceptive Agents; D009761:Nystatin; D000666:Amphotericin B; D010866:Natamycin
Candida-Mykosen der Schleimhaut.